Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8943
|
| pubmed:dateCreated |
1995-2-10
|
| pubmed:abstractText |
An important concern that has received little attention is the possible increased susceptibility to bacterial infections of patients infused with cell-free haemoglobin-based blood substitutes. We show that pyridoxalated polymerised human haemoglobin promotes fulminating Escherichia coli septicaemia in mice, which draws attention to the potential danger of such products in the clinic.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0140-6736
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
21
|
| pubmed:volume |
345
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
158-60
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:7823671-Animals,
pubmed-meshheading:7823671-Blood Substitutes,
pubmed-meshheading:7823671-Disease Susceptibility,
pubmed-meshheading:7823671-Escherichia coli,
pubmed-meshheading:7823671-Escherichia coli Infections,
pubmed-meshheading:7823671-Hemoglobins,
pubmed-meshheading:7823671-Mice,
pubmed-meshheading:7823671-Pyridoxal Phosphate,
pubmed-meshheading:7823671-Sepsis
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Haemoglobin-based blood substitutes and sepsis.
|
| pubmed:affiliation |
National Institute for Biological Standards and Control, South Mimms, Hertfordshire, UK.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|